FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Reverter

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Pablo Gallego; Laura Regué; Joan Roig; Adrian Velazquez-Campoy; David Reverter
Structural Analysis of the Regulation of the DYNLL/LC8 Binding to Nek9 by Phosphorylation.
Raimon Sabate; Alba Espargaro; Ricardo Graña-Montes; David Reverter; Salvador Ventura
Native structure protects SUMO proteins from aggregation into amyloid fibrils.
Giovanni Covaleda; Francesc X Avilés; María A Chávez; Maday Alonso del Rivero; David Reverter
Crystal structure of novel metallocarboxypeptidase inhibitor from marine mollusk Nerita versicolor in complex with human carboxypeptidase A4.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Reverter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pablo Gallego; Laura Regué; Joan Roig; Adrian Velazquez-Campoy; David Reverter
Structural Analysis of the Regulation of the DYNLL/LC8 Binding to Nek9 by Phosphorylation.
The Journal of biological chemistry 2013;288(17):12283-94.
2012: Raimon Sabate; Alba Espargaro; Ricardo Graña-Montes; David Reverter; Salvador Ventura
Native structure protects SUMO proteins from aggregation into amyloid fibrils.
Biomacromolecules 2012;13(6):1916-26.
2012: Giovanni Covaleda; Francesc X Avilés; María A Chávez; Maday Alonso del Rivero; David Reverter
Crystal structure of novel metallocarboxypeptidase inhibitor from marine mollusk Nerita versicolor in complex with human carboxypeptidase A4.
The Journal of biological chemistry 2012;287(12):9250-8.
2012: Jaclyn R Gareau; David Reverter; Christopher D Lima
Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
The Journal of biological chemistry 2012;287(7):4740-51.
2011: Kamela O Alegre; David Reverter
Swapping small ubiquitin-like modifier (SUMO) isoform specificity of SUMO proteases SENP6 and SENP7.
The Journal of biological chemistry 2011;286(41):36142-51.
2008: Christopher D Lima; David Reverter
Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7.
The Journal of biological chemistry 2008;283(46):32045-55.
2004: David Reverter; Klaus Maskos; Fulong Tan; Randal A Skidgel; Wolfram Bode
Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity.
Journal of molecular biology 2004;338(2):257-69.
2002: David Reverter; Marianne Braun; Carlos Fernandez-Catalan; Stefan Strobl; Hiroyuki Sorimachi; Wolfram Bode
Flexibility analysis and structure comparison of two crystal forms of calcium-free human m-calpain.
Biological chemistry 2002;383(9):1415-22.
2001: E Estébanez-Perpiñá; Alex Bayés; Josep Vendrell; Maarten Jongsma; David P Bown; John A Gatehouse; Robert Huber; Wolfram Bode; Francesc X Avilés; David Reverter
Crystal structure of a novel mid-gut procarboxypeptidase from the cotton pest Helicoverpa armigera.
Journal of molecular biology 2001;313(3):629-38.
2001: David Reverter; Hiroyuki Sorimachi; Wolfram Bode
The structure of calcium-free human m-calpain: implications for calcium activation and function.
Trends in cardiovascular medicine 2001;11(6):222-9.
2001: David Reverter; Stefan Strobl; Carlos Fernandez-Catalan; Hiroyuki Sorimachi; Kazutoshi Suzuki; Wolfram Bode
Structural basis for possible calcium-induced activation mechanisms of calpains.
Biological chemistry 2001;382(5):753-66.
2000: David Reverter; C Fernández-Catalán; R Baumgartner; R Pfänder; Robert Huber; Wolfram Bode; Josep Vendrell; Tad A Holak; Francesc X Avilés
Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2.
Nature structural biology 2000;7(4):322-8.
1998: David Reverter; Josep Vendrell; Francesc Canals; J Horstmann; Francesc X Avilés; H Fritz; Christian P Sommerhoff
A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization.
The Journal of biological chemistry 1998;273(49):32927-33.
1998: David Reverter; Salvador Ventura; Virtudes Villegas; Josep Vendrell; Francesc X Avilés
Overexpression of human procarboxypeptidase A2 in Pichia pastoris and detailed characterization of its activation pathway.
The Journal of biological chemistry 1998;273(6):3535-41.
1998: Patrick Aloy; Lluis Catasús; Virtudes Villegas; David Reverter; Josep Vendrell; Francesc X Avilés
Comparative analysis of the sequences and three-dimensional models of human procarboxypeptidases A1, A2 and B.
Biological chemistry 1998;379(2):149-55.
1997: David Reverter; I García-Sáez; Lluis Catasús; Josep Vendrell; Miquel Coll; Francesc X Avilés
Characterisation and preliminary X-ray diffraction analysis of human pancreatic procarboxypeptidase A2.
FEBS letters 1997;420(1):7-10.
1997: I García-Sáez; David Reverter; Josep Vendrell; Francesc X Avilés; Miquel Coll
The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen.
The EMBO journal 1997;16(23):6906-13.
1995: Virtudes Villegas; Ana I Azuaga; Lluis Catasús; David Reverter; Pedro L Mateo; Francesc X Avilés; Luis Serrano
Evidence for a two-state transition in the folding process of the activation domain of human procarboxypeptidase A2.
Biochemistry 1995;34(46):15105-10.